Wednesday, 14 March 2012

Breast Cancer Patients-Max Planck Institute-Lung Research

Researchers discover possible approach to the treatment of aggressive breast cancer

(Max-Planck-Gesellschaft) Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now discovered that they can prevent the formation of metastases by blocking the receptor protein Plexin B1. (Source: EurekAlert! - Medicine and Health) read more..

Breast Cancer Genotype, CYP2D6, Not Predictive of Tamoxifen Benefit

Two studies published today help clarify how to interpret CYP2D6 genetic testing and the results will likely affect the current trend of CYP2D6 genotyping prior to tamoxifen usage in early-stage ER-positive breast cancer patients. (Source: Cancer Network) read more..

No comments:

Post a Comment